for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Business

COVID-19 patients respond to Gilead drug: report

Posted

Gilead Sciences shares surged Friday morning following a media report detailing encouraging partial data from trials of the biotech company's experimental drug remdesivir in severe COVID-19 patients. Fred Katayama reports.

Business

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up